In this podcast we chat to UK consultant haematologist Professor Simon Rule on the recent progress in the understanding and management of Mantle Cell Lymphoma (MCL), and how new agents such as ibrutinib are now firmly established in the treatment algorithm.
This podcast was sponsored by Janssen. The content is based on published studies and the opinions of independent experts. The views expressed are not necessarily those of Janssen.
PLEASE REVIEW PRODUCT INFORMATION BEFORE PRESCRIBING (available from www.janssen.com.au/imbruvica_PI).